Targeting the c-Met/VEGFR Pathway to Boost <i>Nab</i>-Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights.

However, differences did not reach statistical significance, likely due to the limited number of animals per treatment arm.

also in 111,027 other papers

In SNU-1 xenografts with low c-Met expression, monotherapy groups showed a trend toward reduced tumor volume and weight, while combination therapy showed a trend toward greater tumor reduction ( Figure 3 A,B).

also in 53,322 other papers